Aspex US Fund — Form D/A
Aspex US Fund of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2022-03-14. $407.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-03-14
- Form: D/A
- Accession: 0001770201-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.7
- Amount sold: $407.0M
- Minimum investment: $100K
- Investors: 52
- Date of first sale: 2019-03-01
- Security types: fund interests
- SEC file number: 021-334589
Issuer
- Name: Aspex US Fund
- CIK: 0001770201
- Entity type: Other
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2019
- Address: CAYMAN CORPORATE CENTER 27 HOSPITAL ROAD, GEORGE TOWN, GRAND CAYMAN, E9, KY1-9008
- Phone: 13458147600
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Stephen John Rooney | Director | Dunedin, Q2 |
| Stephen John Rooney | Related Person | Dunedin, Q2 |
| JOHN CLIVE LEWIS | Director | GRAND CAYMAN, E9 |
| JOHN CLIVE LEWIS | Related Person | GRAND CAYMAN, E9 |
| n/a Aspex Management (HK) Limited | Executive Officer | Central, K3 |
| n/a Aspex Management (HK) Limited | Related Person | Central, K3 |
| Ho Kei Li | Director | Central, K3 |
| Ho Kei Li | Related Person | Central, K3 |
| n/a Aspex Management (Cayman) Limited | Executive Officer | GRAND CAYMAN, E9 |
Other filings by this issuer (9)
More